Patrys Ltd has released a press release.
Appendix 4E and 2022 Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Patrys
- PAT-DX1 From Engineering Run Meets all Specification Tests
- New Research Grant For Deoxymabs in Metastatic Breast Cancer
- PAT-DX1/Radiation Combination Improves Brain Cancer Survival
- Appendix 4C - Quarterly - 30 June 2022
- PAT-DX1 Engineering Run Successfully Completed
Later from Patrys
- PAT DX3 Crosses Blood Brain Barrier in Healthy Animals
- Appendix 4C - Quarterly - 30 September 2022
- Patrys Appoints Global Biotechnology Leader as Chairman - In Preparation for First Clinical Trial for Groundbreaking Cancer Therapy
- Response to ASX Price Query
- Appendix 4C - Quarterly - 31 December 2022
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys